Issue Highlights page
International Journal of Radiation Oncology*Biology*Physics
; 114(1):A11-A13, 2022.
Article
in English
| EMBASE | ID: covidwho-1984266
antineoplastic agent; brachytherapy; breast cancer; cancer chemotherapy; coronavirus disease 2019; correlational study; dosimetry; drug megadose; editorial; heart disease; high risk patient; human; hypofractionated radiotherapy; irradiation; left anterior descending coronary artery; medial supraclavicular nodal irradiation; medical society; mentor; microbeam irradiation; nonhuman; patient care; patient-reported outcome; phase 2 clinical trial (topic); radiation injury; radiation oncology; reimbursement; residency education; self report; three dimensional printing; thymic epithelial neoplasm; United States; uterine cervix cancer
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
International Journal of Radiation Oncology*Biology*Physics
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS